CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 4 Shares withheld for taxes President and CCO gave up 8,181 shares (to pay taxes)
- 4 Planned sale Chief Legal Officer sold 21,210 shares at $7.65 ($162,257)
- 4 Shares withheld for taxes Chief Executive Officer gave up 27,368 shares (to pay taxes)
- 4 Planned sale Chief Legal Officer sold 161,680 shares at an average $7.21 ($1,164,967)
- 4 Grant or award Director acquired 783 shares (grant or award)
- 4 Grant or award Director acquired 1,566 shares (grant or award)
- 4 Grant or award Director acquired 783 shares (grant or award)
- 4 Planned sale Director sold 9,600 shares at $7.14 ($68,544)
- 4 Grant or award Director acquired 676 shares (grant or award)
- 4 Grant or award Director acquired 1,353 shares (grant or award)
- 4 Grant or award Director acquired 676 shares (grant or award)
- 4 Open-market sale Director sold 70,000 shares at $8.51 ($595,868)
- 4 Grant or award CFO & Head of Corp Development acquired 147,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
Page 3 of 49 · 965 filings